v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Cash flows from operating activities      
Net loss $ (6,457,703) $ (4,608,387)  
Adjustment to reconcile net loss to net cash used in operating activities:      
Equity in losses of investment 3,782  
Bad debt (10,516) 208,729  
Stock-based compensation expense 503,379 301,948  
Amortization of deferred contract cost 118,519  
Non-cash interest expense 769,773  
Depreciation and amortization 1,052,882 2,824  
Foreign currency loss (18,801)  
Change in fair value of convertible notes 1,991,272  
Change in fair value of derivative liability 175,996 (236,917) $ (746,852)
Changes in operating assets and liabilities:      
Accounts receivable (177,832) 234,203  
Prepaid expenses and other current assets 236,339 (631,319)  
Other assets (58,925)  
Accounts payable and accrued liabilities 152,455 975,312  
Deferred revenue 286,637 (101,237)  
Net cash used in operating activities (1,373,818) (3,913,769)  
Cash flows from investing activities      
Developed software additions (704,637) (604,851)  
Furniture, fixtures, and equipment additions (53,621)  
Cash paid for business combinations, net of cash acquired 101,340  
Net cash used in investing activities (704,637) (557,132)  
Cash flows from financing activities      
Value of shares withheld for related to tax withholdings (333,847)  
Net cash (used in) provided by financing activities (333,847)  
Effect of exchange rate changes on cash and restricted cash (1,579)  
Net change in cash and restricted cash (2,413,881) (4,470,901)  
Cash and restricted cash - beginning of period 18,340,640 19,280,897  
Cash and restricted cash - end of period 15,926,759 14,809,996 $ 18,340,640
Cash paid for interest  
Cash paid for taxes  
Supplemental Disclosure of non-cash investing and financing activity:      
Settlement of convertible notes in common stock 8,467,292  
Conversion of exchangeable shares to common stock 7,803,475  
Settlement of other liabilities in common stock $ 377,325  

Source